Thema: Amid
Vir, Biotechnology’s
Vir Biotechnology’s Future Hinges on Clinical Pipeline Amid Financial Pressures - Foto: über boerse-global.de
Vir Biotechnology’s Future Hinges on Clinical Pipeline Amid Financial Pressures
Financial Performance Under Scrutiny
boerse-global.de, 09.09.25 17:27 Uhr
Allogene, Therapeutics
Allogene Therapeutics Stock: Navigating Volatility Amid ...
Financial Position and Market Sentiment
boerse-global.de, 09.09.25 15:36 Uhr
Cintas, Maintains
Cintas Maintains Strong Operational Performance Amid Cost ...
Financial Returns and Strategic Investments
boerse-global.de, 09.09.25 12:09 Uhr
Argentina’s, ETF
Argentina’s ETF Faces Unrelenting Decline Amid Political ...
Investor Flight and Deepening Losses
boerse-global.de, 09.09.25 06:09 Uhr
Viatris, Secures
Viatris Secures European Trademark Victory Amid Ongoing ...
Protecting a Billion-Dollar Brand
boerse-global.de, 08.09.25 17:27 Uhr
Institutional, Backing
Institutional Backing and Strong Fundamentals Bolster Masimo ...
Major Funds Amplify Their Stakes
boerse-global.de, 07.09.25 13:00 Uhr
Origin, Materials
Origin Materials Faces Critical Juncture Amid Production ...
Strategic Pivot and Glimmers of Progress
boerse-global.de, 07.09.25 07:36 Uhr
Tyler, Technologies
Tyler Technologies Secures Major Government Contracts Amid ...
Strong Quarterly Performance Exceeds Expectations
boerse-global.de, 07.09.25 06:27 Uhr
Horizon, Finance
Horizon Finance Secures $40 Million in Convertible Notes ...
Horizon Finance US44045A1025
boerse-global.de, 06.09.25 20:45 Uhr
Cardinal, Health
Cardinal Health Bets Big on Urology with $1.9 Billion Acquisition ...
